Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Clinical interventions in aging

Volumn 4, Issue , 2009, Pages 457-461

  Karagiannis, Dimitrios A ^a   Ladas, Ioannis D ^a   Parikakis, Efstratios ^a   Georgalas, Ilias ^a   Kotsolis, Athanasios ^a   Amariotakis, Giorgos ^a   Soumplis, Vasileios ^a   Mitropoulos, Panagiotis ^a  

^a Ophthalmiatrio of Athens   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; RANIBIZUMAB;

AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 77949519530     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s8367     Document Type: Article

References (0)